★
Trade Filings
Gestores Acciones Declaraciones Superinversores
Señales Compra institucional Venta institucional Actividad de insiders 13D & 13G Watch Rotación sectorial
Herramientas Selector de acciones Filtro de gestores Comparar gestores Cestas de consenso Todas las herramientas de investigación API de datos
Aprender e IA Aprender Consultar los datos Agentes de IA
Noticias ★ Guardado
Acerca de Acerca de nosotros Metodología Contacto Aviso legal
Lector
PLANES DE DATOS

Descargas de datos históricos — disponibles próximamente con cuentas.

GATEWAY DE API

Acceso JSON gratuito de solo lectura a los datos en caché del sitio.
Modo oscuro

🧭 Vista guiada
¿Nuevo en los mercados — precios, rendimientos, YTD, capitalización bursátil? Explicamos cada término mientras navega, en lenguaje claro. Los mismos datos, con la ayuda integrada.

⚡ Opinión experta
Ya conoces el mercado. Solo los datos — limpios, rápidos y compactos, sin explicaciones adicionales. Esta es la vista predeterminada.

Idioma de la interfaz
Ficha del valor · trimestre archivado

LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General

1,233.5 -1.1% cap. de mercado $1.16T cotización diferida (FMP) · a fecha de Aug 25 22:08 UTC — independiente de los datos del archivo a continuación

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
191Tenedores rastreados
-3Δ titulares
666.59MAcciones mantenidas
$613.20BValor declarado
+1Nuevas posiciones
−5Cierres
Stable Puntuación de convicción 40/100 Cómo se calculan estos datos → Explicar esto en el Research Desk →

Señales de momentum (gestores comparables): amplitud de titulares -1.5% · flujo de acciones -0.3% · nuevas posiciones netas -2.1% — fórmula
Distribución amplia — caída de acciones y menos titulares

Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2026

Participación a lo largo del tiempo
TrimestreTitularesΔAccionesValor declaradoNuevoCierres
Q2 2026 193 +4 671.92M $804.91B +6 −1
Q1 2026 191 -3 666.59M $613.20B +1 −5
Q4 2025 193 +2 707.04M $758.81B +3 —
Q3 2025 27 -3 329.88M $251.63B +2 −6
Q2 2025 28 -1 307.45M $239.60B +2 −3
Q1 2025 26 0 140.32M $115.83B +1 −1
Q4 2024 26 +1 145.00M $111.91B +3 −2
Q3 2024 24 +2 109.89M $97.29B +2 —
Q2 2024 22 — 112.43M $101.75B — —
Recuento de titulares
Quién lo tiene en cartera · Q1 2026
#GestorAccionesΔ accionesValorSu ponderaciónMantenida
1 Lilly Endowment Inc 91.90M -0.3% $84.52B 100.0% ▼ Trim 2 SEC ↗
2 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
3 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
4 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
5 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
6 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
7 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
8 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
9 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
10 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
11 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
12 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
13 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
14 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
15 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
16 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
17 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
18 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
19 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
20 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
21 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
22 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
23 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
24 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
25 BlackRock ✦ (pasivo) 66.38M -0.6% $61.06B 1.1% ▼ Trim 4 SEC ↗
26 Vanguard Capital Management Llc 53.36M — $49.08B 1.2% n/c 1 SEC ↗
27 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
28 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
29 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
30 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
31 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
32 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
33 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
34 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
35 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
36 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
37 Pnc Financial Services Group, Inc. 51.33M 0.0% $47.21B 27.3% ▼ Trim 2 SEC ↗
38 State Street Global Advisors ✦ (pasivo) 35.61M +0.7% $32.75B 1.1% ▲ Add 6 SEC ↗
39 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
40 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
41 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
42 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
43 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
44 Fidelity (FMR) ✦ 26.34M +2.4% $24.23B 1.3% ▲ Add 4 SEC ↗
45 Capital Research Global Investors 24.63M +0.3% $22.65B 3.5% ▲ Add 2 SEC ↗
46 Geode Capital Management ✦ (pasivo) 20.19M +1.9% $18.51B 1.2% ▲ Add 8 SEC ↗
47 Geode Capital Management ✦ (pasivo) 20.19M +1.9% $18.51B 1.2% ▲ Add 8 SEC ↗
48 Capital World Investors ✦ 15.62M +3.9% $14.37B 2.0% ▲ Add 8 SEC ↗
49 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
50 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
51 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
52 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
53 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
54 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
55 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
56 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
57 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
58 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
59 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
60 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
61 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
62 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
63 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
64 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
65 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
66 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
67 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
68 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
69 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
70 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
71 Morgan Stanley ✦ 15.44M -1.0% $14.20B 0.9% ▼ Trim 3 SEC ↗
72 T. Rowe Price ✦ 13.99M -6.2% $12.87B 1.5% ▼ Trim 8 SEC ↗
73 T. Rowe Price ✦ 13.99M -6.2% $12.87B 1.5% ▼ Trim 8 SEC ↗
74 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
75 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
76 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
77 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
78 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
79 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
80 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
81 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
82 Wellington Management ✦ 13.43M +0.5% $12.35B 2.3% ▲ Add 8 SEC ↗
83 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
84 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
85 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
86 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
87 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
88 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
89 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
90 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
91 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
92 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
93 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
94 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
95 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
96 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
97 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
98 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
99 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗
100 JPMorgan Chase ✦ 13.70M +5.4% $12.15B 0.8% ▲ Add 3 SEC ↗

«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.

Nuevos compradores

Sin nuevos compradores rastreados este trimestre.

Posición cerrada

Norges Bank $12.98B era 1.4%
Simplex Trading, Llc $2.04M era 0.1%
Group One Trading Llc $1.45M era 0.0%
GQG Partners LLC $666,162 era 0.0%
Alyeska Investment Group, L.P. $560,983 era 0.0%

Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4,323 tenedores, 762.84M acciones, $674.93B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.

Frecuentemente cotituladas

Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.

MSFT190titulares compartidos META189titulares compartidos NVDA189titulares compartidos GOOGL188titulares compartidos AMZN186titulares compartidos
Transacciones de insiders

Compras en mercado abierto (P)

Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.

Ventas en mercado abierto (S)

Aug 17 Jonsson Patrik

Officer · 6.50K acc. · $7.64M

Aug 10 Zakrowski Donald A

Officer · 2.00K acc. · $2.37M

Aug 07 Hakim Anat

Officer · 5.00K acc. · $5.95M

Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología

Propiedad beneficiaria
Jul 23 SC 13G/A — LILLY ENDOWMENT INC

Ver presentación original ante la SEC ↗
En las noticias
Aug 24 FDA Clears Roche And Eli Lilly's Alzheimer's Blood Test ↗

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…

 Forbes
Aug 24 FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly ↗

The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…

 WSJ
Aug 24 Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance ↗

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ​identify signs of…

 Reuters
Aug 24 Eli Lilly Launches Foundayo Weight-Loss Pill in U.K. ↗

The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…

 WSJ
Aug 23 Eli Lilly launches oral weight-loss pill Foundayo in UK ↗

Eli Lilly said on Monday it has launched its oral pill, ​Foundayo, in the UK for weight ‌management and type 2…

 Reuters
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR. Período de reporte: Q1 2026 · Metodología · Obtener esto a través de la API